Novartis Expands in North Carolina, Boosting U.S. Manufacturing

0:00It's April 30th. Welcome in. This is Durham News Today, where local news meets AI. I'm Corey with the story. Novartis just dropped major news on expanding in North Carolina with a new facility in Morse Bill. This is part of their $23 billion push into U.S. manufacturing. The spot will span 56,200 square feet, cranking out solid dosage tablets, capsules, and handling packaging. That builds on their existing footprint right here in the state. They've already got two sites in Durham focused on biologics production, sterile packaging, and filling syringes and vials. For locals and patients, this means more jobs and faster access to meds made stateside. CEO Vasnar Semen says it strengthens their end-to-end setup to develop, produce, and deliver drugs right here. This Morse Bill Plant marks their seventh new U.S. facility announced since 2025. Doctors are popping up in San Diego and Karlsbad in California, Denton in Texas, and Winter Park in Florida.

1:01All this ramps up Novartis' commitment to local innovation, keeping medicines flowing quick and reliable for folks who need them most.